Suchergebnisse - "Exemestane"

PubPharm (37)

1

XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease

enthalten in: Breast cancer research | 2023

von Schmid, P. | Cortes, J. | Joaquim, A. | +13

2

XENERA-1: a randomised double-blind Phase II trial of xentuzumab in combination with everolimus and exemestane versus everolimus and exemestane in patients with hormone receptor-positive/HER2-negative metastatic breast cancer and non-visceral disease

enthalten in: Breast cancer research | 2023

von Schmid, P. | Cortes, J. | Joaquim, A. | +13

3

Patterns of treatment with everolimus exemestane in hormone receptor-positive HER2-negative metastatic breast cancer in the era of targeted therapy

enthalten in: Breast cancer research | 2021

von Rozenblit, M. | Mun, S. | Soulos, P. | +3

4

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA

enthalten in: Breast cancer research | 2015

von Hayes, E. | Lewis-Wambi, J.

5

Mechanisms of endocrine resistance in breast cancer: an overview of the proposed roles of noncoding RNA

enthalten in: Breast cancer research | 2015

von Hayes, E. | Lewis-Wambi, J.

6

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer

enthalten in: Breast cancer research | 2014

von Falahi, F. | van Kruchten, M. | Martinet, N. | +2

7

Current and upcoming approaches to exploit the reversibility of epigenetic mutations in breast cancer

enthalten in: Breast cancer research | 2014

von Falahi, F. | van Kruchten, M. | Martinet, N. | +2

8

Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition

enthalten in: Breast cancer research | 2014

von López-Knowles, E. | Segal, C. | Gao, Q. | +5

9

Relationship of PIK3CA mutation and pathway activity with antiproliferative response to aromatase inhibition

enthalten in: Breast cancer research | 2014

von López-Knowles, E. | Segal, C. | Gao, Q. | +5

10

Impact of dual mTORC1/2 mTOR kinase inhibitor AZD8055 on acquired endocrine resistance in breast cancer in vitro

enthalten in: Breast cancer research | 2014

von Jordan, N. | Dutkowski, C. | Barrow, D. | +5